RECRUITINGPhase 3INTERVENTIONAL
Randomized Withdrawal Study in Patients With Schizophrenia
A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Either Iloperidone Long-Acting Injection (LAI) or Placebo Injection
About This Trial
The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.
Who May Be Eligible (Plain English)
Who May Qualify:
- Males or females 18 to 65 years of age (inclusive)
- Diagnosed with schizophrenia per DSM-5 criteria
- In need of ongoing psychiatric treatment
Who Should NOT Join This Trial:
- DSM-5 diagnosis of a psychiatric disorder other than schizophrenia that was the primary focus of treatment within the previous six months
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Males or females 18 to 65 years of age (inclusive)
* Diagnosed with schizophrenia per DSM-5 criteria
* In need of ongoing psychiatric treatment
Exclusion Criteria:
* DSM-5 diagnosis of a psychiatric disorder other than schizophrenia that was the primary focus of treatment within the previous six months
Treatments Being Tested
DRUG
iloperidone
iloperidone LAI
DRUG
placebo
matching placebo
Locations (20)
Vanda Investigational Site
Rogers, Arkansas, United States
Vanda Investigational Site
Costa Mesa, California, United States
Vanda Investigational Site
Lemon Grove, California, United States
Vanda Investigational Site
Oceanside, California, United States
Vanda Investigational Site
Pico Rivera, California, United States
Vanda Investigational Site
San Diego, California, United States
Vanda Investigational Site
Walnut Creek, California, United States
Vanda Investigational Site
North Miami, Florida, United States
Vanda Investigational Site
Atlanta, Georgia, United States
Vanda Investigational Site
Peachtree Corners, Georgia, United States
Vanda Investigational Site
Chicago, Illinois, United States
Vanda Investigational Site
Flowood, Mississippi, United States
Vanda Investigational Site
Saint Charles, Missouri, United States
Vanda Investigational Site
St Louis, Missouri, United States
Vanda Investigational Site
Las Vegas, Nevada, United States
Vanda Investigational Site
Marlton, New Jersey, United States
Vanda Investigational Site
Staten Island, New York, United States
Vanda Investigational Site
Austin, Texas, United States
Vanda Investigational Site
Houston, Texas, United States
Vanda Investigational Site
Irving, Texas, United States